This Study is a Prospective, Multi-center, Real World, Observational Study, Which Aims at Evaluating Intermediate and Long-term Efficacy of Endovascular Treatment for TASC C&D Aortoiliac Occlusive Disease.
研究单位：[1]Shanghai Zhongshan Hospital[2]RenJi Hospital[3]First Affiliated Hospital of Zhejiang University[4]Chengdu University of Traditional Chinese Medicine[5]Xuanwu Hospital, Beijing[6]First People's Hospital of Hangzhou[7]Qingdao Hiser Medical Group[8]Second Affiliated Hospital of Soochow University[9]Liyuan Hospital of Tongji Medical College of Huazhong University of Science and Technology[10]Huashan Hospital[11]Zhongshan Hospital, Fudan University,Shanghai,China
This study is a prospective, multi-center, real world, observational study, which aims at evaluating the intermediate and long-term efficacy of endovascular treatment for TASC C&D aortoiliac occlusive disease .It is estimated that 800 subjects diagnosed with TASC C&D aortoiliac occlusive disease and receive endovascular treatments will be enrolled in nine centers from April 2021 to June 2027 nation-widely. All the subjects will be under follow-up for 60 months. There is no restriction on the endovascular techniques. The primary outcomes covers freedom from TLR at 60 months.
